Detalles de la búsqueda
1.
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune checkpoint inhibitor endocrinopathies and the role of advanced practice providers in the management of immune-mediated toxicities.
Support Care Cancer
; 28(12): 6175-6181, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32856213
2.
Nivolumab plus ipilimumab in advanced melanoma.
N Engl J Med
; 369(2): 122-33, 2013 Jul 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-23724867
3.
Understanding and Managing Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors in Patients With Advanced Melanoma.
J Adv Pract Oncol
; 8(1): 58-72, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29900017
4.
Pneumonitis in Patients Treated With Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy.
J Clin Oncol
; 35(7): 709-717, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-27646942
5.
Paradoxical activation of T cells via augmented ERK signaling mediated by a RAF inhibitor.
Cancer Immunol Res
; 2(1): 70-9, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24416731
Resultados
1 -
5
de 5
1
Próxima >
>>